Summary
Theα-methyltyrosine-induced disappearance of dopamine was inhibited by the selective dopamine autoreceptor agonist B-HT 920 in the corpus striatum, the nucleus accumbens, the olfactory tubercle, the limbic cortex, and the rostral part of the cerebral cortex of the rat. These inhibitory actions of B-HT 920 were almost completely reversed by the dopamine receptor antagonist haloperidol, indicating that they were caused by a stimulation of dopamine autoreceptors. In the caudal cortex and the cerebellum, the effects of B-HT 920 and haloperidol were less clear, perhaps due to a low concentration of dopamine and to the occurrence of this dopamine in both dopamine and noradrenaline neurons. In the hypothalamus, B-HT 920 and haloperidol did not change theα-methyltyrosine-induced disappearance of dopamine in agreement with previous findings that the tubero-infundibular dopamine neurons are not regulated via dopamine receptors.
Similar content being viewed by others
References
Andén, N.-E.: Regulation of monoamine synthesis and utilization by receptors. In: Adrenergic Activators and Inhibitors, Handbook Exp. Pharmacol. (Szekeres, L., ed.), Vol. 54/I, pp. 429–462. Berlin-Heidelberg-New York: Springer. 1980.
Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci.5, 561–568 (1966).
Andén, N.-E., Golembiowska-Nikitin, K., Thornström, U.: Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively. Naunyn-Schmiedeberg's Arch. Pharmacol.321, 100–104 (1982).
Andén, N.-E., Grabowska-Andén, M., Lindgren, S., Thornström, U.: Synthesis rate of dopamine: difference between corpus striatum and limbic system as a possible explanation of variations in reactions to drugs. Naunyn-Schmiedeberg's Arch. Pharmacol.323, 193–198 (1983 a).
Andén, N.-E., Nilsson, H., Ros, E., Thornström, U.: Effects of B-HT 920 and B-HT 933 on dopamine and noradrenaline autoreceptors in the rat brain. Acta Pharmacol. Toxicol.52, 51–56 (1983 b).
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol.19, 627–629 (1967).
Bannon, M. J., Michaud, R. L., Roth, R. H.: Mesocortical dopamine neurons: lack of autoreceptors modulating dopamine synthesis. Mol. Pharmacol.19, 270–275 (1981).
Bannon, M. J., Reinhard, J. F., jr., Bunney, E. B., Roth, R. H.: Unique response to antipsychotic drugs is due to absence of terminal autoreceptors in mesocortical dopamine neurones. Nature296, 444–446 (1982).
Björklund, A., Lindvall, O., Nobin, A.: Evidence of an incerto-hypothalamic dopamine neurone system in the rat. Brain Res.89, 29–42 (1975).
Carlsson, A.: Receptor-mediated control of dopamine metabolism. In: Preand Postsynaptic Receptors (Usdin, E., Bunney, W. E., eds.), pp.49–65. New York: Marcel Dekker. 1975.
Carlsson, A.: Dopamine receptor agonists: past, present and future. In: Symposium on dopamine receptor agonists (Carlsson, A., Nilsson, J. L. G., eds.) Acta Pharmaceut. Suec, Suppl.1, 11–15 (1983).
Corrodi, H., Hanson, L. C. F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacol.10, 116–125 (1966).
Demarest, K. T., Moore, K. E.: Comparison of dopamine synthesis regulation in the terminals of nigrostriatal, mesolimbic, tuberoinfundibular and tuberohypophyseal neurons. J. Neural Transm.46, 263–277 (1979).
Felice, L. J., Felice, J. D., Kissinger, P. T.: Determination of catecholamines in rat brain parts by reverse-phase ion-pair liquid chromatography. J. Neurochem.31, 1461–1465 (1978).
Fuxe, K.: Cellular localization of monoamines in the median eminence and infundibular stem of some mammals. Acta Physiol. Scand.58, 383–384 (1963).
Grabowska-Andén, M., Andén, N.-E.: Stimulation of postsynaptic DA2 receptors produces jerks in reserpine-treated rats. J. Pharm. Pharmacol.35, 543–545 (1983).
Gudelsky, G. A., Moore, K. E.: Differential drug effects on dopamine concentrations and rates of turnover in the median eminence, olfactory tubercle and corpus striatum. J. Neural Transm.38, 95–105 (1976).
Magnusson, T.: Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryptamine in the rat spinal cord. Naunyn-Schmiedeberg's Arch. Pharmacol.278, 13–22 (1973).
Moore, K. E., Wuerthele, S. M.: Regulation of nigrostriatal and tuberoinfundibular-hypophyseal dopaminergic neurons. Progr. Neurobiol.13, 325–359 (1979).
Nauta, W. J. H., Smith, G. P., Faull, R. L. M., Domesick, V. B.: Efferent connections and nigral afférents of the nucleus accumbens septi in the rat. Neuroscience3, 385–401 (1978).
Nowycky, M. C., Roth, R. H.: Dopaminergic neurons: role of presynaptic receptors in the regulation of transmitter biosynthesis. Progr. Neuro-Psychopharmacol.2, 139–158 (1978).
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis byα-methyl tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther.147, 86–95 (1965).
Umezo, K., Moore, K. E.: Effects of drugs on regional brain concentrations of dopamine and dihydroxyphenylacetic acid. J. Pharmacol. Exp. Ther.208, 49–56 (1979).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Andén, N.E., Grabowska-Andén, M. & Liljenberg, B. On the presence of autoreceptors on dopamine neurons in different brain regions. J. Neural Transmission 57, 129–137 (1983). https://doi.org/10.1007/BF01245113
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01245113